Commerce Bank Halozyme Therapeutics, Inc. Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Commerce Bank holds 10,701 shares of HALO stock, worth $599,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,701

Previous 14,621 26.81%

Holding current value

$599,256

Previous $765,000 20.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$51.3 - $64.42 $201,096 - $252,526	-3,920 Reduced 26.81%	10,701 $612,000
Q1 2024 May 03, 2024	SELL	$33.68 - $41.95 $1,313 - $1,636	-39 Reduced 0.27%	14,621 $594,000
Q4 2023 Feb 09, 2024	SELL	$33.32 - $42.1 $16,026 - $20,250	-481 Reduced 3.18%	14,660 $541,000
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $7,109 - $8,585	-195 Reduced 1.27%	15,141 $578,000
Q2 2023 Aug 08, 2023	SELL	$30.28 - $38.74 $4,814 - $6,159	-159 Reduced 1.03%	15,336 $553,000
Q1 2023 May 04, 2023	SELL	$32.86 - $55.7 $12,552 - $21,277	-382 Reduced 2.41%	15,495 $591,000
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $151,627 - $224,980	-3,785 Reduced 19.25%	15,877 $903,000
Q3 2022 Nov 04, 2022	BUY	$38.53 - $51.78 $27,394 - $36,815	711 Added 3.75%	19,662 $777,000
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $4,220 - $5,457	113 Added 0.6%	18,951 $834,000
Q1 2022 May 09, 2022	SELL	$31.97 - $41.06 $5,083 - $6,528	-159 Reduced 0.84%	18,838 $751,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $104,878 - $134,312	3,296 Added 20.99%	18,997 $763,000
Q3 2021 Nov 09, 2021	BUY	$38.47 - $46.42 $84,287 - $101,706	2,191 Added 16.22%	15,701 $639,000
Q2 2021 Aug 09, 2021	BUY	$38.84 - $51.31 $854 - $1,128	22 Added 0.16%	13,510 $614,000
Q1 2021 May 05, 2021	BUY	$39.51 - $51.45 $110,628 - $144,060	2,800 Added 26.2%	13,488 $562,000
Q4 2020 Feb 09, 2021	BUY	$25.81 - $43.62 $275,857 - $466,210	10,688 New	10,688 $456,000

Others Institutions Holding HALO

# of Institutions

540

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.8B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account